Skip to main content

Amneal Pharmaceuticals, Inc. insider trading

AMRXNASDAQ
$20.30+0.23 (+1.15% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+95.2%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • TBTushar Bhikhubhai Patel10% Owner19.2081%of company
  • CPChintu PatelCo-CEO10.1842%of company
  • CKChirag K. PatelPresident & Co-CEO9.0948%of company
  • GPGautam PatelDirector0.6036%of company
  • PMPaul M. MeisterDirector0.2608%of company
  • TKTasos KonidarisExecutive Vice President & CFO0.1407%of company
  • JPJeffrey P. GeorgeDirector0.1079%of company
  • TCTed C. NarkDirector0.102%of company
  • SYShlomo YanaiDirector0.1005%of company
  • NSNikita ShahExecutive Vice President0.0793%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
AMRXJohn KielyDirectorOpen market sell$882K-19.2%$17.64$882KAug 13, 2026Aug 14, 2026
AMRXNikita ShahExecutive Vice PresidentOpen market sell$2.56M-36.6%$17.51$2.56MAug 12, 2026Aug 13, 2026
AMRXJason B. DalyEVP, Chief Legal OfficerOpen market sell$3.65M-85.7%$17.40$3.65MAug 12, 2026Aug 13, 2026
AMRXJason B. DalyEVP, Chief Legal OfficerOpen market sell$117K-2.6%$17.70$117KAug 11, 2026Aug 13, 2026
AMRXDeborah M. AutorDirectorOpen market sell$451K-27.1%$12.94$451KMay 11, 2026May 12, 2026
AMRXTed C. NarkDirectorOpen market sell$586K-14.7%$11.72$586KNov 17, 2025Nov 19, 2025
End of history · 6 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.